Responses
Poster Presentation
Preliminary results of the Phase IIa trial of a folate binding protein (FBP) adjuvant cancer vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence
Compose a Response to This Article
Other responses
No responses have been published for this article.